320 related articles for article (PubMed ID: 14659807)
1. Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury.
Hausenloy DJ; Duchen MR; Yellon DM
Cardiovasc Res; 2003 Dec; 60(3):617-25. PubMed ID: 14659807
[TBL] [Abstract][Full Text] [Related]
2. Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection.
Hausenloy D; Wynne A; Duchen M; Yellon D
Circulation; 2004 Apr; 109(14):1714-7. PubMed ID: 15066952
[TBL] [Abstract][Full Text] [Related]
3. Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart.
Javadov SA; Clarke S; Das M; Griffiths EJ; Lim KH; Halestrap AP
J Physiol; 2003 Jun; 549(Pt 2):513-24. PubMed ID: 12692185
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?
Hausenloy DJ; Maddock HL; Baxter GF; Yellon DM
Cardiovasc Res; 2002 Aug; 55(3):534-43. PubMed ID: 12160950
[TBL] [Abstract][Full Text] [Related]
5. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Liu YN; Zhou ZM; Chen P
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial permeability transition pore as a target for cardioprotection in the human heart.
Shanmuganathan S; Hausenloy DJ; Duchen MR; Yellon DM
Am J Physiol Heart Circ Physiol; 2005 Jul; 289(1):H237-42. PubMed ID: 15961375
[TBL] [Abstract][Full Text] [Related]
7. Intermittent high altitude hypoxia inhibits opening of mitochondrial permeability transition pores against reperfusion injury.
Zhu WZ; Xie Y; Chen L; Yang HT; Zhou ZN
J Mol Cell Cardiol; 2006 Jan; 40(1):96-106. PubMed ID: 16288778
[TBL] [Abstract][Full Text] [Related]
8. Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A.
Clarke SJ; McStay GP; Halestrap AP
J Biol Chem; 2002 Sep; 277(38):34793-9. PubMed ID: 12095984
[TBL] [Abstract][Full Text] [Related]
9. Urocortin prevents mitochondrial permeability transition in response to reperfusion injury indirectly by reducing oxidative stress.
Townsend PA; Davidson SM; Clarke SJ; Khaliulin I; Carroll CJ; Scarabelli TM; Knight RA; Stephanou A; Latchman DS; Halestrap AP
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H928-38. PubMed ID: 17483234
[TBL] [Abstract][Full Text] [Related]
10. Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Petrosillo G; Colantuono G; Moro N; Ruggiero FM; Tiravanti E; Di Venosa N; Fiore T; Paradies G
Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1487-93. PubMed ID: 19684190
[TBL] [Abstract][Full Text] [Related]
11. The role of mitochondria in protection of the heart by preconditioning.
Halestrap AP; Clarke SJ; Khaliulin I
Biochim Biophys Acta; 2007 Aug; 1767(8):1007-31. PubMed ID: 17631856
[TBL] [Abstract][Full Text] [Related]
12. Age-associated differences in the inhibition of mitochondrial permeability transition pore opening by cyclosporine A.
Liu L; Zhu J; Brink PR; Glass PS; Rebecchi MJ
Acta Anaesthesiol Scand; 2011 May; 55(5):622-30. PubMed ID: 21827445
[TBL] [Abstract][Full Text] [Related]
13. Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore.
Lim SY; Davidson SM; Hausenloy DJ; Yellon DM
Cardiovasc Res; 2007 Aug; 75(3):530-5. PubMed ID: 17512507
[TBL] [Abstract][Full Text] [Related]
14. The mitochondrial permeability transition pore and the Ca2+-activated K+ channel contribute to the cardioprotection conferred by tumor necrosis factor-alpha.
Gao Q; Zhang SZ; Cao CM; Bruce IC; Xia Q
Cytokine; 2005 Dec; 32(5):199-205. PubMed ID: 16260145
[TBL] [Abstract][Full Text] [Related]
15. Opening of mitochondrial permeability transition pore induces hypercontracture in Ca2+ overloaded cardiac myocytes.
Ruiz-Meana M; Abellán A; Miró-Casas E; Garcia-Dorado D
Basic Res Cardiol; 2007 Nov; 102(6):542-52. PubMed ID: 17891523
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial permeability transition pore opening during myocardial reperfusion--a target for cardioprotection.
Halestrap AP; Clarke SJ; Javadov SA
Cardiovasc Res; 2004 Feb; 61(3):372-85. PubMed ID: 14962470
[TBL] [Abstract][Full Text] [Related]
17. Elucidating Mitochondrial Electron Transport Chain Supercomplexes in the Heart During Ischemia-Reperfusion.
Jang S; Lewis TS; Powers C; Khuchua Z; Baines CP; Wipf P; Javadov S
Antioxid Redox Signal; 2017 Jul; 27(1):57-69. PubMed ID: 27604998
[TBL] [Abstract][Full Text] [Related]
18. Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening.
Bhamra GS; Hausenloy DJ; Davidson SM; Carr RD; Paiva M; Wynne AM; Mocanu MM; Yellon DM
Basic Res Cardiol; 2008 May; 103(3):274-84. PubMed ID: 18080084
[TBL] [Abstract][Full Text] [Related]
19. Uncoupling protein 3 mediates H₂O₂ preconditioning-afforded cardioprotection through the inhibition of MPTP opening.
Chen Y; Liu J; Zheng Y; Wang J; Wang Z; Gu S; Tan J; Jing Q; Yang H
Cardiovasc Res; 2015 Feb; 105(2):192-202. PubMed ID: 25514931
[TBL] [Abstract][Full Text] [Related]
20. HIF-1 reduces ischaemia-reperfusion injury in the heart by targeting the mitochondrial permeability transition pore.
Ong SG; Lee WH; Theodorou L; Kodo K; Lim SY; Shukla DH; Briston T; Kiriakidis S; Ashcroft M; Davidson SM; Maxwell PH; Yellon DM; Hausenloy DJ
Cardiovasc Res; 2014 Oct; 104(1):24-36. PubMed ID: 25063991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
